INDV Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Indivior PLC for Potential Securities Law Violations We are investigating Indivior for potential violations of the federal securities laws.

Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug SAN FRANCISCO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- DURECT Corp. (DRRX:NASDAQ), a biopharmaceutical company, noted that Indivior Plc announced that it will launch in the U.S. its drug for the treatment...